血清游离轻链升高与慢性淋巴细胞白血病及单克隆B淋巴细胞增多症的关联
Association of elevated serumfree light chains with chronic lymphocytic leukemia and monoclonal B-cell lymphocytosis
原文发布日期:2019-08-05
DOI: 10.1038/s41408-019-0220-x
类型: Article
开放获取: 是
英文摘要:
摘要翻译:
原文链接:
Chronic lymphocytic leukemia (CLL) and its precursor, monoclonal B-cell lymphocytosis (MBL), are heritable. Serumfree light-chain (sFLC) measures are a prognostic factor for CLL, but their role in susceptibility to CLL is not clear. We investigated differences between sFLC measurements in pre-treatment serum from five groups to inform the association of sFLC with familial and sporadic CLL: (1) familial CLL (n = 154), (2) sporadic CLL (n = 302), (3) familial MBL (n = 87), (4) unaffected first-degree relatives from CLL/MBL families (n = 263), and (5) reference population (n = 15,396). The percent of individuals having elevated monoclonal and polyclonal sFLCs was compared using age-stratified and age- and sex-adjusted logistic regression models. In age groups >50 years, monoclonal sFLC elevations were increased in sporadic and familial CLL cases compared to the reference population (p’s < 0.05). However, there were no statistically significant differences in sFLC monoclonal or polyclonal elevations between familial and sporadic CLL cases (p’s > 0.05). Unaffected relatives and MBL cases from CLL/MBL families, ages >60 years, showed elevated monoclonal sFLC, compared to the reference population (p’s < 0.05). This is the first study to demonstrate monoclonal sFLC elevations in CLL cases compared to controls. Monoclonal sFLC levels may provide additional risk information in relatives of CLL probands.
慢性淋巴细胞白血病(CLL)及其前体——单克隆B细胞淋巴细胞增多症(MBL)具有遗传性。血清游离轻链(sFLC)检测是CLL的预后指标,但其在CLL易感性中的作用尚不明确。我们通过分析五组人群治疗前血清的sFLC测量值差异,探讨sFLC与家族性和散发性CLL的关联:(1)家族性CLL(n=154);(2)散发性CLL(n=302);(3)家族性MBL(n=87);(4)CLL/MBL家族中未受累的一级亲属(n=263);(5)参照人群(n=15,396)。采用年龄分层及经年龄、性别调整的逻辑回归模型,比较各组单克隆性与多克隆性sFLC升高者的百分比。在年龄>50岁的人群中,散发性与家族性CLL患者的单克隆sFLC升高比例均显著高于参照人群(P值均<0.05)。但家族性与散发性CLL病例间的单克隆或多克隆sFLC升高无统计学差异(P值均>0.05)。在年龄>60岁的CLL/MBL家族成员中,未受累亲属及MBL患者的单克隆sFLC水平均高于参照人群(P值均<0.05)。本研究首次证实CLL患者存在相较于对照组的单克隆sFLC升高现象。单克隆sFLC水平或可为CLL先证者亲属提供额外的风险信息。
……